Gerresheimer has significantly ramped up its glass and plastic production capacities in India to satisfy its global pharma customer needs.
A new modern plant to produce high quality plastic containers and closures was built at the Kosamba site, and glass production received a new state-of-the-art and sustainable furnace technology. This is in line with the company's formula G growth strategy.
By adding capacities in India, Gerresheimer executes its growth strategy in Emerging Markets addressing the global mega trend for increasing health care access in these markets and the rising demand for vaccination. For which, the company produces the primary packaging.
Being a leading partner for global pharma and healthcare customers, Gerresheimer already operates in India. The new production capabilities combine the company's know-how and network in glass and plastic, offering solutions alongside the broad Gerresheimer portfolio.
Over the previous two years, the company invested a double-digit million Euro amount into new furnaces in Kosamba
"With our outstanding portfolio in pharma and healthcare solutions, Gerresheimer is contributing to the health and well-being of millions of patients worldwide. India is one of the strongest growing country within the Emerging Markets and a core market of large global pharma companies," said CEO Dietmar Siemssen. "Our new facilities in India are another important step to serve global pharma customers locally as a one stop shop - with the highest quality and availability."
Improving technology along the way
Gerresheimer follows a clear roadmap for further global capacity increases alongside its holistic capital allocation process. The capacity increase in India is part of Gerresheimer's investment programme to sharpen the company's growth and return profile.
Over the previous two years, the company invested a double-digit million Euro amount into new furnaces in Kosamba with the latest glass melting technology.
The new state of the art furnace is equipped with the newest production machines, and also has the most sensitive inspection equipment following the Gerresheimer molded glass production standards. With this technology, the company will substantially enhance its product quality.
New lines for glass injection vials as well as solid plastic dosages, closures and security systems have also been ramped up.
Further enhancing Gerresheimer's local production and sales footprint in Emerging Markets is part of the company's regional expansion plans.
